Administration, Intravenous
"Administration, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of substances through VENIPUNCTURE into the VEINS.
| Descriptor ID |
D061605
|
| MeSH Number(s) |
E02.319.267.082
|
| Concept/Terms |
Administration, Intravenous- Administration, Intravenous
- Administrations, Intravenous
- Intravenous Administrations
- Intravenous Administration
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravenous".
This graph shows the total number of publications written about "Administration, Intravenous" by people in this website by year, and whether "Administration, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 3 | 3 |
| 2018 | 0 | 8 | 8 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 6 | 6 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravenous" by people in Profiles.
-
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. N Engl J Med. 2022 07 14; 387(2):148-159.
-
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. Br J Cancer. 2022 03; 126(4):640-651.
-
IFN?-stimulated dendritic cell extracellular vesicles can be nasally administered to the brain and enter oligodendrocytes. PLoS One. 2021; 16(8):e0255778.
-
Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410.
-
Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181). Clin Transl Sci. 2021 01; 14(1):277-287.
-
In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma. Aging (Albany NY). 2020 11 16; 12(22):22949-22974.
-
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. 2020 09 15; 324(11):1048-1057.
-
Retrospective Study of Midazolam Protocol for Prehospital Behavioral Emergencies. West J Emerg Med. 2020 Apr 21; 21(3):677-683.
-
N-Oxide polymer-cupric ion nanogels potentiate disulfiram for cancer therapy. Biomater Sci. 2020 Mar 17; 8(6):1726-1733.
-
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic Analyses. Adv Ther. 2020 04; 37(4):1464-1478.